Tandem Labs General Information
Provider of services as a contract research organization (CRO), serving the pharmaceutical, biopharmaceutical, and biotechnology industries. The company develops, validates, and performs spectrometry-based methods in support of clinical, pre-clinical, and discovery studies in a stringent GLP environment. It offers GLP bioanalytical services, such as method development and validation, dose formulation analysis, pre-clinical and clinical sample analysis, TK/PK analysis and reporting, and protein-binding studies; as well as rapid turnaround non-GLP discovery services, including protein-binding assays, and discovery bioanalysis. It also provides GLP immunoanalytical services, which include biomarker assay development, validation, and sample analysis; ligand-binding, immunogenicity, and cell-based assays; biotherapeutic macromolecule PK; and electrochemiluminescence, quantitative immunoassays, and multiplexed assays. It has supported nearly 100 pharmaceutical, biopharmaceutical, and biotechnical clients.